Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2020 4
2021 6
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Unilateral focused ultrasound subthalamotomy in early Parkinson's disease: a pilot study.
Martínez Fernández R, Natera Villalba E, Rodriguez-Rojas R, Del Álamo M, Pineda-Pardo JA, Obeso I, Mata-Marín D, Guida P, Jimenez-Castellanos T, Pérez-Bueno D, Duque A, Máñez Miró JU, Gasca-Salas C, Matarazzo M, Obeso JA. Martínez Fernández R, et al. Among authors: natera villalba e. J Neurol Neurosurg Psychiatry. 2024 Feb 14;95(3):206-213. doi: 10.1136/jnnp-2023-331211. J Neurol Neurosurg Psychiatry. 2024. PMID: 37673642
Prospective Long-term Follow-up of Focused Ultrasound Unilateral Subthalamotomy for Parkinson Disease.
Martínez-Fernández R, Natera-Villalba E, Máñez Miró JU, Rodriguez-Rojas R, Marta Del Álamo M, Pineda-Pardo JÁ, Ammann C, Obeso I, Mata-Marín D, Hernández-Fernández F, Gasca-Salas C, Matarazzo M, Alonso-Frech F, Obeso JA. Martínez-Fernández R, et al. Among authors: natera villalba e. Neurology. 2023 Mar 28;100(13):e1395-e1405. doi: 10.1212/WNL.0000000000206771. Epub 2023 Jan 11. Neurology. 2023. PMID: 36631272 Free PMC article. Clinical Trial.
Update in the clinical application of focused ultrasound.
Natera-Villalba E, Matarazzo M, Martinez-Fernandez R. Natera-Villalba E, et al. Curr Opin Neurol. 2022 Aug 1;35(4):525-535. doi: 10.1097/WCO.0000000000001073. Epub 2022 Jul 5. Curr Opin Neurol. 2022. PMID: 35788096 Review.
Eye-of-the-Tiger Sign with an Unexpected Pathological Diagnosis.
Natera-Villalba E, Martínez-Castrillo JC, López-Sendón Moreno JL, Gómez-López A, Sánchez-Sánchez A, López-Martínez MJ, Rábano A, Alonso-Cánovas A. Natera-Villalba E, et al. Mov Disord Clin Pract. 2021 Nov 7;9(1):98-103. doi: 10.1002/mdc3.13366. eCollection 2022 Jan. Mov Disord Clin Pract. 2021. PMID: 35005073 Free PMC article.
SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease.
Gómez-López A, Sánchez-Sánchez A, Natera-Villalba E, Ros-Castelló V, Beltrán-Corbellini Á, Fanjul-Arbós S, Pareés Moreno I, López-Sendon Moreno JL, Martínez Castrillo JC, Alonso-Canovas A. Gómez-López A, et al. Among authors: natera villalba e. Brain Sci. 2021 Jan 6;11(1):57. doi: 10.3390/brainsci11010057. Brain Sci. 2021. PMID: 33418858 Free PMC article.
The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19.
Monreal E, Sainz de la Maza S, Fernández-Velasco JI, Natera-Villalba E, Rita CG, Rodríguez-Jorge F, Beltrán-Corbellini Á, Iturrieta-Zuazo I, Rodríguez de Santiago E, Espiño M, de Andrés A, Fortún J, Barbero E, Vázquez M, Fernández Lucas M, Manzano L, Montero-Errasquín B, Costa-Frossard L, Masjuan J, Villar LM; COVID-HRC group. Monreal E, et al. Among authors: natera villalba e. J Clin Immunol. 2021 Feb;41(2):315-323. doi: 10.1007/s10875-020-00927-y. Epub 2020 Nov 24. J Clin Immunol. 2021. PMID: 33236261 Free PMC article.
Use of the Cardiovascular Polypill in Secondary Prevention of Cerebrovascular Disease: A Real-Life Tertiary Hospital Cohort Study of 104 Patients.
Ros-Castelló V, Natera-Villalba E, Gómez-López A, Sánchez-Sánchez A, Chico-García JL, García-Madrona S, Vera-Lechuga R, Matute-Lozano C, de Felipe Mimbrera A, Cruz-Culebras A, Alonso-Canovas A, Masjuan J. Ros-Castelló V, et al. Among authors: natera villalba e. Cerebrovasc Dis Extra. 2020;10(3):166-173. doi: 10.1159/000511064. Epub 2020 Nov 11. Cerebrovasc Dis Extra. 2020. PMID: 33176324 Free PMC article.
Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
Monreal E, Maza S S, Gullón P, Natera-Villalba E, Chico-García JL, Beltrán-Corbellini Á, Martínez-Sanz J, García-Barragán N, Buisán J, Toledano R, Alonso-Canovas A, Pérez-Torre P, Matute-Lozano MC, López-Sendón JL, García-Ribas G, Corral Í, Fortún J, Montero-Errasquín B, Manzano L, Máiz-Carro L, Costa-Frossard L, Masjuan J; COVID-HRC Group. Monreal E, et al. Among authors: natera villalba e. J Med Virol. 2021 Apr;93(4):2243-2251. doi: 10.1002/jmv.26656. Epub 2020 Nov 22. J Med Virol. 2021. PMID: 33165922
13 results